Sleeping through the trip: scientists test psilocybin under anesthesia for depression
NCT ID NCT07479550
Summary
This study is testing a new method to improve research on psilocybin, a psychedelic compound, for treating major depression. To make the study more scientifically rigorous, participants will receive psilocybin or a placebo while under general anesthesia, so they won't know which they got. The goal is to see if this approach is safe and feasible, and to gather early data on whether it helps reduce depression symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Stanford University
Stanford, California, 94304, United States
Contact Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.